European Heart Journal, ISSN 0195-668X, 1/2008, Volume 29, Issue 2, pp. 185 - 190
Aims Torsades de pointes arrhythmias (TdP) occur by definition in the setting of prolonged QT intervals. Animal models of drug induced Long-QT syndrome (dLQTS)...
Beat-to-beat Variability of repolarization Proarrhythmia | Drug induced Long QT Syndrome | Torsades de Pointes | drug induced long QT syndrome | ARRHYTHMIAS | TORSADES-DE-POINTES | CARDIAC & CARDIOVASCULAR SYSTEMS | HEARTS | beat-to-beat variability of repolarization proarrhythmia | TACHYCARDIA | UNMASKS | PROLONGATION | REPOLARIZATION | SOTALOL | THERAPY | DOGS | Predictive Value of Tests | Disease Susceptibility | Humans | Middle Aged | Torsades de Pointes - chemically induced | Electrocardiography - drug effects | Long QT Syndrome - chemically induced | Male | Arrhythmias, Cardiac - etiology | Case-Control Studies | Heart Rate - drug effects | Pilot Projects | Heart Rate - physiology | Female | Aged | Torsades de Pointes - physiopathology
Beat-to-beat Variability of repolarization Proarrhythmia | Drug induced Long QT Syndrome | Torsades de Pointes | drug induced long QT syndrome | ARRHYTHMIAS | TORSADES-DE-POINTES | CARDIAC & CARDIOVASCULAR SYSTEMS | HEARTS | beat-to-beat variability of repolarization proarrhythmia | TACHYCARDIA | UNMASKS | PROLONGATION | REPOLARIZATION | SOTALOL | THERAPY | DOGS | Predictive Value of Tests | Disease Susceptibility | Humans | Middle Aged | Torsades de Pointes - chemically induced | Electrocardiography - drug effects | Long QT Syndrome - chemically induced | Male | Arrhythmias, Cardiac - etiology | Case-Control Studies | Heart Rate - drug effects | Pilot Projects | Heart Rate - physiology | Female | Aged | Torsades de Pointes - physiopathology
Journal Article
Journal of Cardiovascular Pharmacology, ISSN 0160-2446, 09/2014, Volume 64, Issue 3, pp. 266 - 276
Isolated hearts with reduced repolarization reserve would be suitable for assessing the proarrhythmic liability of drugs. However, it is not known which...
Repolarization reserve | Langendorff perfused rabbit heart | Absolute beat-to-beat variability parameters | Biomarkers of proarrhythmia | Torsades de pointes | biomarkers of proarrhythmia | torsades de pointes | TORSADES-DE-POINTES | DOFETILIDE | CARDIAC & CARDIOVASCULAR SYSTEMS | CANINE MODEL | INSTABILITY | repolarization reserve | absolute beat-to-beat variability parameters | VENTRICULAR REPOLARIZATION | QT INTERVAL VARIABILITY | ACTION-POTENTIAL DURATION | IN-VIVO MODEL | PHARMACOLOGICAL BLOCK | PHARMACOLOGY & PHARMACY | CHANNEL BLOCKER | Biomarkers - metabolism | Rabbits | Phenethylamines - toxicity | Arrhythmias, Cardiac - chemically induced | Phenethylamines - pharmacology | Torsades de Pointes - chemically induced | Sulfonamides - pharmacology | Arrhythmias, Cardiac - physiopathology | Dose-Response Relationship, Drug | Phenethylamines - administration & dosage | Animals | Chromans - pharmacology | Electrocardiography | Female | Sulfonamides - toxicity | Chromans - toxicity | Torsades de Pointes - physiopathology | Chromans - administration & dosage | Sulfonamides - administration & dosage
Repolarization reserve | Langendorff perfused rabbit heart | Absolute beat-to-beat variability parameters | Biomarkers of proarrhythmia | Torsades de pointes | biomarkers of proarrhythmia | torsades de pointes | TORSADES-DE-POINTES | DOFETILIDE | CARDIAC & CARDIOVASCULAR SYSTEMS | CANINE MODEL | INSTABILITY | repolarization reserve | absolute beat-to-beat variability parameters | VENTRICULAR REPOLARIZATION | QT INTERVAL VARIABILITY | ACTION-POTENTIAL DURATION | IN-VIVO MODEL | PHARMACOLOGICAL BLOCK | PHARMACOLOGY & PHARMACY | CHANNEL BLOCKER | Biomarkers - metabolism | Rabbits | Phenethylamines - toxicity | Arrhythmias, Cardiac - chemically induced | Phenethylamines - pharmacology | Torsades de Pointes - chemically induced | Sulfonamides - pharmacology | Arrhythmias, Cardiac - physiopathology | Dose-Response Relationship, Drug | Phenethylamines - administration & dosage | Animals | Chromans - pharmacology | Electrocardiography | Female | Sulfonamides - toxicity | Chromans - toxicity | Torsades de Pointes - physiopathology | Chromans - administration & dosage | Sulfonamides - administration & dosage
Journal Article
Journal of Cardiovascular Electrophysiology, ISSN 1045-3873, 06/2019, Volume 30, Issue 6, pp. 941 - 949
Introduction Higher progesterone concentrations are protective against drug‐induced prolongation of ventricular repolarization. We tested the hypothesis that...
QT interval | beat‐to‐beat variability | torsades de pointes | isolated perfused heart | ventricular arrhythmias | progesterone | rabbit | dofetilide | beat-to-beat variability | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIAC REPOLARIZATION | SEX | RISK | QT INTERVAL PROLONGATION | HORMONE REPLACEMENT THERAPY | STEROID-HORMONES | TO-BEAT VARIABILITY | PROARRHYTHMIA | ESTRADIOL | Heart | Rabbits | Tachycardia | Electrocardiogram | Estrogen | Electrocardiography | Dofetilide | Progesterone | EKG | Ovariectomy | Implantation | Ablation | Estradiol | Nodes | Incidence | Sex hormones | Perfusion | Torsades de pointes | Sustained release | Ventricle | Pretreatment | Controlled release | Prolongation
QT interval | beat‐to‐beat variability | torsades de pointes | isolated perfused heart | ventricular arrhythmias | progesterone | rabbit | dofetilide | beat-to-beat variability | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIAC REPOLARIZATION | SEX | RISK | QT INTERVAL PROLONGATION | HORMONE REPLACEMENT THERAPY | STEROID-HORMONES | TO-BEAT VARIABILITY | PROARRHYTHMIA | ESTRADIOL | Heart | Rabbits | Tachycardia | Electrocardiogram | Estrogen | Electrocardiography | Dofetilide | Progesterone | EKG | Ovariectomy | Implantation | Ablation | Estradiol | Nodes | Incidence | Sex hormones | Perfusion | Torsades de pointes | Sustained release | Ventricle | Pretreatment | Controlled release | Prolongation
Journal Article
Heart Rhythm, ISSN 1547-5271, 2011, Volume 8, Issue 7, pp. 1050 - 1057
Background Repolarization variability is considered to predict sudden cardiac death. T-wave alternans (TWA) has been the subject of exhaustive research,...
Cardiovascular | Beat-to-beat variability of repolarization | Noninvasive risk stratification | T-wave alternans | Sudden cardiac death | Ischemic cardiomyopathy | ARRHYTHMIAS | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | SUDDEN | RISK STRATIFICATION | ISCHEMIA | DEATH | LEFT-VENTRICULAR DYSFUNCTION | CARDIAC ALTERNANS | DEFIBRILLATOR | CORONARY-ARTERY-DISEASE | Cardiac Resynchronization Therapy - methods | Tachycardia, Ventricular - complications | Follow-Up Studies | Death, Sudden, Cardiac - prevention & control | Death, Sudden, Cardiac - etiology | Magnetic Resonance Imaging, Cine | Tachycardia, Ventricular - physiopathology | Ventricular Remodeling | Animals | Heart Conduction System - physiopathology | Time Factors | Swine | Myocardial Ischemia - complications | Tachycardia, Ventricular - diagnosis | Death, Sudden, Cardiac - pathology | Electrocardiography | Heart Rate - physiology | Myocardial Ischemia - physiopathology | Disease Models, Animal | Implants, Artificial | Prosthesis | Electrocardiogram | Universities and colleges | Cardiology | Heart attack | Adenosine triphosphatase
Cardiovascular | Beat-to-beat variability of repolarization | Noninvasive risk stratification | T-wave alternans | Sudden cardiac death | Ischemic cardiomyopathy | ARRHYTHMIAS | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | SUDDEN | RISK STRATIFICATION | ISCHEMIA | DEATH | LEFT-VENTRICULAR DYSFUNCTION | CARDIAC ALTERNANS | DEFIBRILLATOR | CORONARY-ARTERY-DISEASE | Cardiac Resynchronization Therapy - methods | Tachycardia, Ventricular - complications | Follow-Up Studies | Death, Sudden, Cardiac - prevention & control | Death, Sudden, Cardiac - etiology | Magnetic Resonance Imaging, Cine | Tachycardia, Ventricular - physiopathology | Ventricular Remodeling | Animals | Heart Conduction System - physiopathology | Time Factors | Swine | Myocardial Ischemia - complications | Tachycardia, Ventricular - diagnosis | Death, Sudden, Cardiac - pathology | Electrocardiography | Heart Rate - physiology | Myocardial Ischemia - physiopathology | Disease Models, Animal | Implants, Artificial | Prosthesis | Electrocardiogram | Universities and colleges | Cardiology | Heart attack | Adenosine triphosphatase
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 12/2006, Volume 149, Issue 8, pp. 1039 - 1048
Background & purpose: The therapeutically available quinolone antibiotic moxifloxacin has been used as a positive control for prolonging the QT interval in...
short‐term variability | torsades de pointes | electrophysiology | acquired long QT | proarrhythmia | action potential | beat‐to‐beat variability of repolarization | Beat-to-beat variability of repolarization | Short-term variability | Torsades de pointes | Acquired long QT | Electrophysiology | Action potential | Proarrhythmia | TORSADES-DE-POINTES | HEALTHY-SUBJECTS | RISK | beat-to-beat variability of repolarization | PROLONGATION | LONG-QT SYNDROME | short-term variability | REPOLARIZATION | CONSCIOUS DOGS | ACTION-POTENTIAL DURATION | EARLY AFTERDEPOLARIZATIONS | PHARMACOLOGY & PHARMACY | Fluoroquinolones | Arrhythmias, Cardiac - chemically induced | Electric Stimulation | Phenethylamines - pharmacology | Anti-Arrhythmia Agents - pharmacology | Heart Block - physiopathology | Torsades de Pointes - chemically induced | Azithromycin - toxicity | Long QT Syndrome - chemically induced | Aza Compounds - toxicity | Sulfonamides - pharmacology | Arrhythmias, Cardiac - physiopathology | Long QT Syndrome - physiopathology | Dose-Response Relationship, Drug | Heart Rate - drug effects | Animals | Electroencephalography - drug effects | Dogs | Anesthesia | Anti-Bacterial Agents - toxicity | Torsades de Pointes - physiopathology | Quinolines - toxicity | Research Papers
short‐term variability | torsades de pointes | electrophysiology | acquired long QT | proarrhythmia | action potential | beat‐to‐beat variability of repolarization | Beat-to-beat variability of repolarization | Short-term variability | Torsades de pointes | Acquired long QT | Electrophysiology | Action potential | Proarrhythmia | TORSADES-DE-POINTES | HEALTHY-SUBJECTS | RISK | beat-to-beat variability of repolarization | PROLONGATION | LONG-QT SYNDROME | short-term variability | REPOLARIZATION | CONSCIOUS DOGS | ACTION-POTENTIAL DURATION | EARLY AFTERDEPOLARIZATIONS | PHARMACOLOGY & PHARMACY | Fluoroquinolones | Arrhythmias, Cardiac - chemically induced | Electric Stimulation | Phenethylamines - pharmacology | Anti-Arrhythmia Agents - pharmacology | Heart Block - physiopathology | Torsades de Pointes - chemically induced | Azithromycin - toxicity | Long QT Syndrome - chemically induced | Aza Compounds - toxicity | Sulfonamides - pharmacology | Arrhythmias, Cardiac - physiopathology | Long QT Syndrome - physiopathology | Dose-Response Relationship, Drug | Heart Rate - drug effects | Animals | Electroencephalography - drug effects | Dogs | Anesthesia | Anti-Bacterial Agents - toxicity | Torsades de Pointes - physiopathology | Quinolines - toxicity | Research Papers
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 08/2007, Volume 151, Issue 7, pp. 909 - 911
The pharmaceutical industry is testing new potential drugs for their propensity to prolong human cardiac repolarization, and regards this as a sign of...
torsades de pointes | electrophysiology | repolarization reserve | drug research | action potential | proarrhythmia | beat‐to‐beat variability of repolarization | long QT | Beat-to-beat variability of repolarization | Repolarization reserve | Drug research | Torsades de pointes | Long QT | Electrophysiology | Action potential | Proarrhythmia | TORSADES-DE-POINTES | beat-to-beat variability of repolarization | I-KS | VENTRICULAR-MUSCLE | QT PROLONGATION | VARIABILITY | PHARMACOLOGY & PHARMACY | Phenethylamines - toxicity | Drug-Related Side Effects and Adverse Reactions - prevention & control | Potassium Channels, Voltage-Gated - physiology | Drug-Related Side Effects and Adverse Reactions - chemically induced | Humans | Long QT Syndrome - chemically induced | Long QT Syndrome - physiopathology | Phenethylamines - administration & dosage | Delayed Rectifier Potassium Channels - physiology | Potassium Channel Blockers - toxicity | Torsades de Pointes - physiopathology | Chromans - administration & dosage | Rabbits | Delayed Rectifier Potassium Channels - antagonists & inhibitors | Potassium Channel Blockers - administration & dosage | Risk Factors | Torsades de Pointes - chemically induced | Electrocardiography - drug effects | Potassium Channels, Voltage-Gated - antagonists & inhibitors | Drug Synergism | Animals | Dogs | Sulfonamides - toxicity | Chromans - toxicity | Sulfonamides - administration & dosage | Commentaries
torsades de pointes | electrophysiology | repolarization reserve | drug research | action potential | proarrhythmia | beat‐to‐beat variability of repolarization | long QT | Beat-to-beat variability of repolarization | Repolarization reserve | Drug research | Torsades de pointes | Long QT | Electrophysiology | Action potential | Proarrhythmia | TORSADES-DE-POINTES | beat-to-beat variability of repolarization | I-KS | VENTRICULAR-MUSCLE | QT PROLONGATION | VARIABILITY | PHARMACOLOGY & PHARMACY | Phenethylamines - toxicity | Drug-Related Side Effects and Adverse Reactions - prevention & control | Potassium Channels, Voltage-Gated - physiology | Drug-Related Side Effects and Adverse Reactions - chemically induced | Humans | Long QT Syndrome - chemically induced | Long QT Syndrome - physiopathology | Phenethylamines - administration & dosage | Delayed Rectifier Potassium Channels - physiology | Potassium Channel Blockers - toxicity | Torsades de Pointes - physiopathology | Chromans - administration & dosage | Rabbits | Delayed Rectifier Potassium Channels - antagonists & inhibitors | Potassium Channel Blockers - administration & dosage | Risk Factors | Torsades de Pointes - chemically induced | Electrocardiography - drug effects | Potassium Channels, Voltage-Gated - antagonists & inhibitors | Drug Synergism | Animals | Dogs | Sulfonamides - toxicity | Chromans - toxicity | Sulfonamides - administration & dosage | Commentaries
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 12/2010, Volume 161, Issue 7, pp. 1477 - 1495
BACKGROUND AND PURPOSE Torsades de pointes (TdP) liability is a stochastic event, which indicates that unidentified factors have an important role in...
Absolute beat-to-beat variability and instability | Baroreflex | Torsades de pointes | Phenylephrine | Anaesthetized rabbit | Biomarkers | Dofetilide | adrenoceptor stimulation | Coupling interval | Preceding arrhythmias | preceding arrhythmias | ARRHYTHMIAS | torsades de pointes | D-SOTALOL | baroreflex | SHORT-TERM VARIABILITY | biomarkers | DELAYED REPOLARIZATION | coupling interval | PROLONGATION | dofetilide | ALPHA-ADRENOCEPTOR STIMULATION | alpha 1-adrenoceptor stimulation | anaesthetized rabbit | absolute beat-to-beat variability and instability | IN-VIVO MODEL | PROARRHYTHMIA | phenylephrine | SYMPATHETIC-NERVE ACTIVITY | PHARMACOLOGY & PHARMACY | LONG-QT-SYNDROME
Absolute beat-to-beat variability and instability | Baroreflex | Torsades de pointes | Phenylephrine | Anaesthetized rabbit | Biomarkers | Dofetilide | adrenoceptor stimulation | Coupling interval | Preceding arrhythmias | preceding arrhythmias | ARRHYTHMIAS | torsades de pointes | D-SOTALOL | baroreflex | SHORT-TERM VARIABILITY | biomarkers | DELAYED REPOLARIZATION | coupling interval | PROLONGATION | dofetilide | ALPHA-ADRENOCEPTOR STIMULATION | alpha 1-adrenoceptor stimulation | anaesthetized rabbit | absolute beat-to-beat variability and instability | IN-VIVO MODEL | PROARRHYTHMIA | phenylephrine | SYMPATHETIC-NERVE ACTIVITY | PHARMACOLOGY & PHARMACY | LONG-QT-SYNDROME
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 01/2010, Volume 159, Issue 1, pp. 77 - 92
Background and purpose: Evaluation of the potential for delayed ventricular repolarization and proarrhythmia by new drugs is essential. We investigated if dog...
Purkinje fibres | triangulation | left ventricular midmyocardial myocytes | action potential duration | beat‐to‐beat variability of repolarization | Beat-to-beat variability of repolarization | Triangulation | Action potential duration | Left ventricular midmyocardial myocytes | FEMALE RABBIT HEART | TORSADES-DE-POINTES | POTASSIUM CHANNELS | beat-to-beat variability of repolarization | QT INTERVAL PROLONGATION | CANINE PURKINJE-FIBERS | I-KS | ISOLATED CARDIAC-MUSCLE | DURATION PROLONGATION | PHARMACOLOGY & PHARMACY | ATRIOVENTRICULAR-BLOCK | OPTICAL ISOMERS | Drug Evaluation, Preclinical - methods | Risk Assessment - methods | Heart Ventricles - cytology | Purkinje Fibers - metabolism | Animals | Myocytes, Cardiac - drug effects | Purkinje Fibers - drug effects | Drug-Related Side Effects and Adverse Reactions | Dogs | Drug Design | Myocytes, Cardiac - metabolism | Female | Action Potentials - drug effects | Heart Ventricles - drug effects | Cardiac arrhythmia | Risk assessment | Themed Section
Purkinje fibres | triangulation | left ventricular midmyocardial myocytes | action potential duration | beat‐to‐beat variability of repolarization | Beat-to-beat variability of repolarization | Triangulation | Action potential duration | Left ventricular midmyocardial myocytes | FEMALE RABBIT HEART | TORSADES-DE-POINTES | POTASSIUM CHANNELS | beat-to-beat variability of repolarization | QT INTERVAL PROLONGATION | CANINE PURKINJE-FIBERS | I-KS | ISOLATED CARDIAC-MUSCLE | DURATION PROLONGATION | PHARMACOLOGY & PHARMACY | ATRIOVENTRICULAR-BLOCK | OPTICAL ISOMERS | Drug Evaluation, Preclinical - methods | Risk Assessment - methods | Heart Ventricles - cytology | Purkinje Fibers - metabolism | Animals | Myocytes, Cardiac - drug effects | Purkinje Fibers - drug effects | Drug-Related Side Effects and Adverse Reactions | Dogs | Drug Design | Myocytes, Cardiac - metabolism | Female | Action Potentials - drug effects | Heart Ventricles - drug effects | Cardiac arrhythmia | Risk assessment | Themed Section
Journal Article
Annals of Noninvasive Electrocardiology, ISSN 1082-720X, 11/2014, Volume 19, Issue 6, pp. 582 - 594
Background Guanfacine (Intuniv) is a centrally active alpha‐2A adrenergic agonist for the new indication of attention‐deficit/hyperactivity disorder. QTc (QTcF...
QTc/QT prolongation | risk assessment | restitution | beat‐to‐beat | guanfacine | arrhythmia | beat-to-beat | VARIABILITY | DE-POINTES | CARDIAC & CARDIOVASCULAR SYSTEMS | REPOLARIZATION | Risk Assessment - methods | Arrhythmias, Cardiac - chemically induced | Double-Blind Method | Electrocardiography, Ambulatory - drug effects | Guanfacine - pharmacology | Humans | Electrocardiography, Ambulatory - methods | Long QT Syndrome - chemically induced | Male | Reference Values | Adrenergic alpha-2 Receptor Agonists - pharmacology | Cross-Over Studies | Dose-Response Relationship, Drug | Female | Retrospective Studies | Fluoroquinolones - administration & dosage | Hypertension | Usage | Arrhythmia | Electrocardiogram | Anti-arrhythmia drugs | Electrocardiography | Guanfacine | Attention deficit disorder | Drug therapy | Restitution
QTc/QT prolongation | risk assessment | restitution | beat‐to‐beat | guanfacine | arrhythmia | beat-to-beat | VARIABILITY | DE-POINTES | CARDIAC & CARDIOVASCULAR SYSTEMS | REPOLARIZATION | Risk Assessment - methods | Arrhythmias, Cardiac - chemically induced | Double-Blind Method | Electrocardiography, Ambulatory - drug effects | Guanfacine - pharmacology | Humans | Electrocardiography, Ambulatory - methods | Long QT Syndrome - chemically induced | Male | Reference Values | Adrenergic alpha-2 Receptor Agonists - pharmacology | Cross-Over Studies | Dose-Response Relationship, Drug | Female | Retrospective Studies | Fluoroquinolones - administration & dosage | Hypertension | Usage | Arrhythmia | Electrocardiogram | Anti-arrhythmia drugs | Electrocardiography | Guanfacine | Attention deficit disorder | Drug therapy | Restitution
Journal Article
Journal of Electrocardiology, ISSN 0022-0736, 2011, Volume 44, Issue 4, pp. 477.e1 - 477.e9
Abstract Background Increased beat-to-beat variability in cardiac repolarization time is a tentative risk marker of drug-induced torsades de pointes. We...
Cardiovascular | Repolarization instability | Automatic analysis | Beat-to-beat | QT variability | Humans | Middle Aged | Linear Models | Male | Reference Values | Arrhythmias, Cardiac - physiopathology | Analysis of Variance | Time Factors | Heart Conduction System - physiology | Adolescent | Aged, 80 and over | Electrocardiography | Adult | Female | Aged | Kardiologi | Cardiac and Cardiovascular Systems
Cardiovascular | Repolarization instability | Automatic analysis | Beat-to-beat | QT variability | Humans | Middle Aged | Linear Models | Male | Reference Values | Arrhythmias, Cardiac - physiopathology | Analysis of Variance | Time Factors | Heart Conduction System - physiology | Adolescent | Aged, 80 and over | Electrocardiography | Adult | Female | Aged | Kardiologi | Cardiac and Cardiovascular Systems
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 06/2005, Volume 145, Issue 3, pp. 397 - 404
1 The rate of infusion has been suggested to be important for drug‐induced torsades de pointes (TdP) arrhythmias. We investigated the repolarisation‐prolonging...
beat‐to‐beat variability of repolarisation | short‐term variability | torsades de pointes | Electrophysiology | acquired long QT | infusion rate | proarrhythmia | action potential | Short-term variability | Torsades de pointes | Acquired long QT | Action potential | Beat-to-beat variability of repolarisation | Infusion rate | Proarrhythmia | ARRHYTHMIAS | PROTEIN-KINASE | NA+/CA2+ CHANNEL | PROLONGATION | LONG-QT SYNDROME | short-term variability | NEUROPROTECTIVE AGENT | CA2+ CHANNEL BLOCKER | electrophysiology | EARLY AFTERDEPOLARIZATIONS | PHARMACOLOGY & PHARMACY | COMPLETE AV-BLOCK | beat-to-beat variability of repolarisation | CEREBRAL-ISCHEMIA | Predictive Value of Tests | Animals | Arrhythmias, Cardiac - chemically induced | Time Factors | Infusion Pumps | Pyrimidines - administration & dosage | Dogs | Torsades de Pointes - chemically induced | Infusions, Intravenous | Torsades de Pointes - physiopathology | Arrhythmias, Cardiac - physiopathology | Papers
beat‐to‐beat variability of repolarisation | short‐term variability | torsades de pointes | Electrophysiology | acquired long QT | infusion rate | proarrhythmia | action potential | Short-term variability | Torsades de pointes | Acquired long QT | Action potential | Beat-to-beat variability of repolarisation | Infusion rate | Proarrhythmia | ARRHYTHMIAS | PROTEIN-KINASE | NA+/CA2+ CHANNEL | PROLONGATION | LONG-QT SYNDROME | short-term variability | NEUROPROTECTIVE AGENT | CA2+ CHANNEL BLOCKER | electrophysiology | EARLY AFTERDEPOLARIZATIONS | PHARMACOLOGY & PHARMACY | COMPLETE AV-BLOCK | beat-to-beat variability of repolarisation | CEREBRAL-ISCHEMIA | Predictive Value of Tests | Animals | Arrhythmias, Cardiac - chemically induced | Time Factors | Infusion Pumps | Pyrimidines - administration & dosage | Dogs | Torsades de Pointes - chemically induced | Infusions, Intravenous | Torsades de Pointes - physiopathology | Arrhythmias, Cardiac - physiopathology | Papers
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 2011, Volume 672, Issue 1, pp. 126 - 134
The novel antiarrhythmic drug K201 (4‐[3-{1-(4‐benzyl)piperidinyl}propionyl]‐7‐methoxy‐2,3,4,5‐tetrahydro‐1,4‐benzothiazepine monohydrochloride) is currently...
Ventricular arrhythmia | Beat-to-beat variability of repolarization duration | K201 | Safety pharmacology | Cardiac electrophysiology | JTV519 | D-SOTALOL | PIG VENTRICULAR MYOCYTES | HEART-FAILURE | SPONTANEOUS CA2+ RELEASE | NA/CA EXCHANGE | CELLULAR BASIS | TO-BEAT VARIABILITY | EARLY AFTERDEPOLARIZATIONS | RYANODINE RECEPTOR | PHARMACOLOGY & PHARMACY | CARDIOPROTECTIVE DRUG | Membrane Potentials - drug effects | Atrioventricular Block - physiopathology | Disease Susceptibility | Anti-Arrhythmia Agents - pharmacology | Torsades de Pointes - chemically induced | Male | Thiazepines - pharmacology | Atrioventricular Block - pathology | Dose-Response Relationship, Drug | Torsades de Pointes - pathology | Animals | Time Factors | Phenethylamines - adverse effects | Dogs | Sulfonamides - adverse effects | Anesthesia | Female | Torsades de Pointes - physiopathology | Chronic Disease | Torsades de Pointes - prevention & control | Animal experimentation | Analysis | Heart block | Atrial fibrillation | Anti-arrhythmia drugs
Ventricular arrhythmia | Beat-to-beat variability of repolarization duration | K201 | Safety pharmacology | Cardiac electrophysiology | JTV519 | D-SOTALOL | PIG VENTRICULAR MYOCYTES | HEART-FAILURE | SPONTANEOUS CA2+ RELEASE | NA/CA EXCHANGE | CELLULAR BASIS | TO-BEAT VARIABILITY | EARLY AFTERDEPOLARIZATIONS | RYANODINE RECEPTOR | PHARMACOLOGY & PHARMACY | CARDIOPROTECTIVE DRUG | Membrane Potentials - drug effects | Atrioventricular Block - physiopathology | Disease Susceptibility | Anti-Arrhythmia Agents - pharmacology | Torsades de Pointes - chemically induced | Male | Thiazepines - pharmacology | Atrioventricular Block - pathology | Dose-Response Relationship, Drug | Torsades de Pointes - pathology | Animals | Time Factors | Phenethylamines - adverse effects | Dogs | Sulfonamides - adverse effects | Anesthesia | Female | Torsades de Pointes - physiopathology | Chronic Disease | Torsades de Pointes - prevention & control | Animal experimentation | Analysis | Heart block | Atrial fibrillation | Anti-arrhythmia drugs
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 01/2012, Volume 165, Issue 2, pp. 467 - 478
BACKGROUND AND PURPOSE Drug development requires the testing of new chemical entities for adverse effects. For cardiac safety screening, improved assays are...
human embryonic stem cell‐derived cardiomyocytes | methoxamine‐sensitized rabbit | chronic AV block dog | dofetilide | cardiac safety pharmacology | isolated cardiomyocytes | beat‐to‐beat variability of repolarization | moxifloxacin | TORSADES-DE-POINTES | CANINE MODEL | CARDIAC REPOLARIZATION | SHORT-TERM VARIABILITY | HEALTHY-SUBJECTS | POTASSIUM CHANNELS | human embryonic stem cell-derived cardiomyocytes | beat-to-beat variability of repolarization | LONG-QT SYNDROME | TO-BEAT VARIABILITY | EMBRYONIC STEM-CELLS | PHARMACOLOGY & PHARMACY | ATRIOVENTRICULAR-BLOCK | methoxamine-sensitized rabbit | Fluoroquinolones | Embryonic Stem Cells - cytology | Anti-Arrhythmia Agents - pharmacology | Humans | Heart Block - physiopathology | Aza Compounds - pharmacology | Quinolines - pharmacology | Piperidines - pharmacology | Female | Torsades de Pointes - physiopathology | Methoxamine | Action Potentials - drug effects | Potassium Channel Blockers - pharmacology | Disease Models, Animal | Heart - physiopathology | Cell Line | Rabbits | Phenethylamines - pharmacology | Torsades de Pointes - chemically induced | Sulfonamides - pharmacology | Animals | Myocytes, Cardiac - drug effects | Myocytes, Cardiac - physiology | Dogs | Heart - drug effects | Pyridines - pharmacology | Ventricular Remodeling - drug effects | Medical research | Cardiomyocytes | Stem cells | Index Medicus | Research Papers
human embryonic stem cell‐derived cardiomyocytes | methoxamine‐sensitized rabbit | chronic AV block dog | dofetilide | cardiac safety pharmacology | isolated cardiomyocytes | beat‐to‐beat variability of repolarization | moxifloxacin | TORSADES-DE-POINTES | CANINE MODEL | CARDIAC REPOLARIZATION | SHORT-TERM VARIABILITY | HEALTHY-SUBJECTS | POTASSIUM CHANNELS | human embryonic stem cell-derived cardiomyocytes | beat-to-beat variability of repolarization | LONG-QT SYNDROME | TO-BEAT VARIABILITY | EMBRYONIC STEM-CELLS | PHARMACOLOGY & PHARMACY | ATRIOVENTRICULAR-BLOCK | methoxamine-sensitized rabbit | Fluoroquinolones | Embryonic Stem Cells - cytology | Anti-Arrhythmia Agents - pharmacology | Humans | Heart Block - physiopathology | Aza Compounds - pharmacology | Quinolines - pharmacology | Piperidines - pharmacology | Female | Torsades de Pointes - physiopathology | Methoxamine | Action Potentials - drug effects | Potassium Channel Blockers - pharmacology | Disease Models, Animal | Heart - physiopathology | Cell Line | Rabbits | Phenethylamines - pharmacology | Torsades de Pointes - chemically induced | Sulfonamides - pharmacology | Animals | Myocytes, Cardiac - drug effects | Myocytes, Cardiac - physiology | Dogs | Heart - drug effects | Pyridines - pharmacology | Ventricular Remodeling - drug effects | Medical research | Cardiomyocytes | Stem cells | Index Medicus | Research Papers
Journal Article
International Heart Journal, ISSN 1349-2365, 2011, Volume 52, Issue 5, pp. 304 - 307
In order to begin searching for new markers for safe exercise training in patients with cardiac diseases, we tested the sensitivity and reliability of the...
Repolarization reserve | Beat to beat variability of repolarization | Spatial dispersion | Temporal dispersion | Cardiac rehabilitation | ARRHYTHMIAS | CARDIAC & CARDIOVASCULAR SYSTEMS | PREVENTION | DEATH | SOCIETY | HEART | TO-BEAT VARIABILITY | QT INTERVALS
Repolarization reserve | Beat to beat variability of repolarization | Spatial dispersion | Temporal dispersion | Cardiac rehabilitation | ARRHYTHMIAS | CARDIAC & CARDIOVASCULAR SYSTEMS | PREVENTION | DEATH | SOCIETY | HEART | TO-BEAT VARIABILITY | QT INTERVALS
Journal Article
Canadian Journal of Physiology and Pharmacology, ISSN 0008-4212, 04/2015, Volume 93, Issue 9, pp. 765 - 772
Stratification models for the prediction of sudden cardiac death (SCD) are inappropriate in patients with hypertrophic cardiomyopathy (HCM). We investigated...
Repolarization | QT prolongation | Tpeak–Tend interval | Left ventricular hypertrophy | Hypertrophic cardiomyopathy | Sudden cardiac death | Short-term beat-to-beat variability of the QT interval | QT dispersion | LATE SODIUM CURRENT | TORSADES-DE-POINTES | PHYSIOLOGY | RISK-FACTORS | MYOCYTES | DISPERSION | HEART-FAILURE | repolarization | Tpeak-Tend interval | sudden cardiac death | END INTERVAL | left ventricular hypertrophy | PHARMACOLOGY & PHARMACY | hypertrophic cardiomyopathy | REPOLARIZATION LABILITY | short-term beat-to-beat variability of the QT interval | TEND INTERVAL | Echocardiography | Humans | Middle Aged | Male | Cardiomyopathy, Hypertrophic - complications | Arrhythmias, Cardiac - physiopathology | Case-Control Studies | Magnetic Resonance Imaging | Cardiomyopathy, Hypertrophic - physiopathology | Hypertrophy, Left Ventricular - pathology | Hypertrophy, Left Ventricular - complications | Electrocardiography | Adult | Female | Arrhythmias, Cardiac - complications | Hypertrophy, Left Ventricular - physiopathology | Cardiomyopathy, Hypertrophic | Diagnosis | Heart enlargement | Electrocardiogram | Methods | Heart | Care and treatment
Repolarization | QT prolongation | Tpeak–Tend interval | Left ventricular hypertrophy | Hypertrophic cardiomyopathy | Sudden cardiac death | Short-term beat-to-beat variability of the QT interval | QT dispersion | LATE SODIUM CURRENT | TORSADES-DE-POINTES | PHYSIOLOGY | RISK-FACTORS | MYOCYTES | DISPERSION | HEART-FAILURE | repolarization | Tpeak-Tend interval | sudden cardiac death | END INTERVAL | left ventricular hypertrophy | PHARMACOLOGY & PHARMACY | hypertrophic cardiomyopathy | REPOLARIZATION LABILITY | short-term beat-to-beat variability of the QT interval | TEND INTERVAL | Echocardiography | Humans | Middle Aged | Male | Cardiomyopathy, Hypertrophic - complications | Arrhythmias, Cardiac - physiopathology | Case-Control Studies | Magnetic Resonance Imaging | Cardiomyopathy, Hypertrophic - physiopathology | Hypertrophy, Left Ventricular - pathology | Hypertrophy, Left Ventricular - complications | Electrocardiography | Adult | Female | Arrhythmias, Cardiac - complications | Hypertrophy, Left Ventricular - physiopathology | Cardiomyopathy, Hypertrophic | Diagnosis | Heart enlargement | Electrocardiogram | Methods | Heart | Care and treatment
Journal Article